IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i23p8707-d449919.html
   My bibliography  Save this article

Alternative Tobacco Product Use in Critically Ill Patients

Author

Listed:
  • Tom Liu

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA
    Virginia Tech Carilion School of Medicine, Roanoke, VA 24014, USA
    Rutgers—New Jersey Medical School, East Orange, NJ 07103, USA)

  • Thomas J. Deiss

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA)

  • Matthew W. Lippi

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA
    Center for Tobacco Control Research and Education, University of California, San Francisco, CA 94143, USA)

  • Alejandra Jauregui

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA)

  • Kathryn Vessel

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA)

  • Serena Ke

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA
    Center for Tobacco Control Research and Education, University of California, San Francisco, CA 94143, USA)

  • Annika Belzer

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA)

  • Hanjing Zhuo

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA)

  • Kirsten N. Kangelaris

    (Department of Medicine, Division of Hospital Medicine, University of California, San Francisco, CA 94143, USA)

  • Antonio D. Gomez

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA 94143, USA)

  • Michael A. Matthay

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA
    Department of Anesthesia, University of California, San Francisco, CA 94143, USA)

  • Kathleen D. Liu

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Department of Anesthesia, University of California, San Francisco, CA 94143, USA
    Department of Medicine, Division of Nephrology, University of California, San Francisco, CA 94143, USA)

  • Carolyn S. Calfee

    (Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143, USA
    Cardiovascular Research Institute, University of California, San Francisco, CA 94143, USA
    Center for Tobacco Control Research and Education, University of California, San Francisco, CA 94143, USA
    Department of Anesthesia, University of California, San Francisco, CA 94143, USA)

Abstract

Background: Alternative tobacco product (ATP) use has bee linked to critical illness, however, few studies have examined the use of these substances in critically ill populations. We sought to examine ATP use within critically ill patients and to define barriers in accurately assessing use within this population. Methods: We prospectively studied 533 consecutive patients from the Early Assessment of Renal and Lung Injury study, enrolled between 2013 and 2016 at a tertiary referral center and a safety-net hospital. ATP use information (electronic cigarettes, cigars, pipes, hookahs/waterpipes, and snus/chewing tobacco) was obtained from the patient or surrogate using a detailed survey. Reasons for non-completion of the survey were recorded, and differences between survey responders vs. non-responders, self- vs. surrogate responders, and ATP users vs. non-users were explored. Results: Overall, 80% ( n = 425) of subjects (56% male) completed a tobacco product use survey. Of these, 12.2% ( n = 52) reported current ATP use, while 5.6% reported using multiple ATP products. When restricted to subjects who were self-responders, 17% reported ATP use, while 10% reported current cigarette smoking alone. The mean age of ATP users was 57 ± 17 years. Those who did not complete a survey were sicker and more likely to have died during admission. Subjects who completed the survey as self-responders reported higher levels of ATP use than ones with surrogate responders ( p < 0.0001). Conclusion: ATP use is common among critically ill patients despite them being generally older than traditional users. Survey self-responders were more likely than surrogate responders to report use. These findings highlight the importance of improving our current methods of surveillance of ATP use in older adults in the outpatient setting.

Suggested Citation

  • Tom Liu & Thomas J. Deiss & Matthew W. Lippi & Alejandra Jauregui & Kathryn Vessel & Serena Ke & Annika Belzer & Hanjing Zhuo & Kirsten N. Kangelaris & Antonio D. Gomez & Michael A. Matthay & Kathleen, 2020. "Alternative Tobacco Product Use in Critically Ill Patients," IJERPH, MDPI, vol. 17(23), pages 1-14, November.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:23:p:8707-:d:449919
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/23/8707/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/23/8707/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Popova, L. & Ling, P.M., 2013. "Alternative tobacco product use and smoking cessation: a national study," American Journal of Public Health, American Public Health Association, vol. 103(5), pages 923-930.
    2. Popova, L. & Ling, P.M., 2013. "Alternative tobacco product use and smoking cessation: A national study," American Journal of Public Health, American Public Health Association, vol. 103(5), pages 923-930.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jennifer R. Mendel & Marissa G. Hall & Sabeeh A. Baig & Michelle Jeong & Noel T. Brewer, 2018. "Placing Health Warnings on E-Cigarettes: A Standardized Protocol," IJERPH, MDPI, vol. 15(8), pages 1-14, July.
    2. Cheryl Rivard & Anthony Brown & Karin Kasza & Maansi Bansal-Travers & Andrew Hyland, 2021. "Home Tobacco Use Policies and Exposure to Secondhand Tobacco Smoke: Findings from Waves 1 through 4 of the Population Assessment of Tobacco and Health (PATH) Study," IJERPH, MDPI, vol. 18(18), pages 1-10, September.
    3. Ying Xu & Yanfang Guo & Kaiqian Liu & Zheng Liu & Xiaobo Wang, 2016. "E-Cigarette Awareness, Use, and Harm Perception among Adults: A Meta-Analysis of Observational Studies," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-18, November.
    4. Konstantinos E. Farsalinos & Giorgio Romagna & Dimitris Tsiapras & Stamatis Kyrzopoulos & Vassilis Voudris, 2014. "Characteristics, Perceived Side Effects and Benefits of Electronic Cigarette Use: A Worldwide Survey of More than 19,000 Consumers," IJERPH, MDPI, vol. 11(4), pages 1-18, April.
    5. Shannon Gravely & Geoffrey T. Fong & K. Michael Cummings & Mi Yan & Anne C. K. Quah & Ron Borland & Hua-Hie Yong & Sara C. Hitchman & Ann McNeill & David Hammond & James F. Thrasher & Marc C. Willemse, 2014. "Awareness, Trial, and Current Use of Electronic Cigarettes in 10 Countries: Findings from the ITC Project," IJERPH, MDPI, vol. 11(11), pages 1-14, November.
    6. Tomoyasu Hirano & Takahiro Tabuchi & Rika Nakahara & Naoki Kunugita & Yumiko Mochizuki-Kobayashi, 2017. "Electronic Cigarette Use and Smoking Abstinence in Japan: A Cross-Sectional Study of Quitting Methods," IJERPH, MDPI, vol. 14(2), pages 1-9, February.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:23:p:8707-:d:449919. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.